Mometasone furoate is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions. It has a glucocorticoid receptor binding affinity 22 times stronger than dexamethasone and higher than many other corticosteroids as well. Mometasone furoate is formulated as a dry powder inhaler, nasal spray, and ointment for its ...
Inhaled mometasone furoate is indicated for prophylaxis of asthma in patients ≥4 years. Applied topically as an ointment, mometasone furoate is indicated for symptomatic treatment of dermatitis and pruritis in patients ≥2 years.
...
Mount Sinai St Luke's, New York, New York, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
GSK Investigational Site, Rotherham, United Kingdom
CPCAD, Nice, Cedex, France
Novartis Investigative Site, Wiltshire, United Kingdom
Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran, Islamic Republic of
Samsung Medical Center, Irwon-dong, Gangnam-gu, Seoul, Korea, Republic of
ENT dept, NÄL Hospital, Trollhättan, Sweden
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.